FIELD: medicine, chemical and pharmaceutical industry.
SUBSTANCE: claimed composition contains as active ingredient 11-beta, 16-alpha, 17-alpha, 21-tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene03,20-dione or pharmaceutically acceptable salt thereof as well as 1-(para-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine or pharmaceutically acceptable salt thereof. As target additives composition contains lactose, microcrystalline cellulose, crospovidone and magnesium stearate.
EFFECT: composition of prolonged action and high effectiveness useful in treatment of both allergic and inflammation diseases.
4 cl, 10 ex
